Investorideas.com

Get great ideas from our AI, cannabis, cleantech, crypto, esports and mining podcasts - be a guest or sponsor : 800 665 0411


Share on StockTwits

Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 427 (TSXV: NUMI) (CSE: IPOT) (TSXV: RTI) (OTC: ERBB)

 

Delta, Kelowna, BC - June 11, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/061120-StocksToWatch.mp3

Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 427 (TSXV: NUMI) (CSE: IPOT) (TSXV: RTI) (OTC: ERBB)

SHARE PODCAST:      

Hear Investor ideas cannabis potcast on iTunes

Hear the investor ideas potcast on Spotify

Today's podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today's podcast we look at a few public and private company announcements.

Numinus Wellness Inc. (TSX-V:NUMI) (OTC: LKYSD) announced receiving Health Canada approval to amend the Company's existing Licence under the Controlled Drug and Substances Act to allow Numinus researchers to conduct research to standardize the extraction of psilocybin from mushrooms. The amendment means Numinus is the first publicly traded company in Canada to be granted a licence by Health Canada to conduct research of this kind.

With this regulatory approval, Numinus is able to proceed with the production of naturally sourced, sustainable psilocybin for research purposes that will support the emerging field of psychedelic assisted therapy and research, at lower costs to currently produced synthetic psilocybin. The licence also allows Numinus to develop and licence its own exclusive IP for further product development in partnership with leading research organizations - something the research community has been seeking to secure. The work will be eligible for the Government of Canada's Scientific Research and Experimental Development (SR&ED) tax incentive program and will lay a foundation for grant applications.

"We are proud to be at the forefront of a new therapeutic category by advancing evidence-based science focused on wellness and personal connection at its core," says Numinus CEO Payton Nyquvest. "Numinus is the only publicly traded company in Canada approved to develop a consistent psilocybin extraction method from naturally-produced mushrooms at a time when alternative therapeutic methods are increasingly being investigated and demand from clinical research is growing."

Working from the 7,000 square-foot Numinus Bioscience research facility and laboratory, senior research scientists Dr. Kristina Grotzinger and Dr. Bernd Keller will focus on developing a proprietary extraction method from mushrooms to allow for consistent dosing and application of naturally produced psilocybin. Once a proprietary method has been developed, the Company intends to explore supply agreements with leading research organizations to make use of the product in their clinical and therapeutic work.

Researchers at Johns Hopkins University, the Multidisciplinary Association for Psychedelic Substances (MAPS) and other leading researchers have published studies showing the benefits of psilocybin in treating Post-Traumatic Stress Disorder (PTSD) and other mental health issues. Further, the US Food and Drug Administration has granted breakthrough therapy status for psilocybin for the treatment of PTSD - illustrating the growing demand for therapeutic access to psilocybin.

"In most cases, the creation of synthetic compounds are less pure than those found in nature, which is the case with psilocybin," says Dr. Grotzinger. "There is risk of contamination from solvents, gases and other chemicals, which makes them less safe to work with and requires added safety and processing expense. By working directly with the mushroom in its natural state, these risks are reduced, as is the cost to extract the psilocybin." Grotzinger added that standardized plant or fungi extracts are accepted by European standards and are a common dosage form in Europe.

Isracann Biosciences Inc. (CSE: IPOT) (OTC: ISCNF), an Israel-based company focused on becoming a premier low cost, high quality cannabis producer announced its support of recent news reports signaling a move towards increased legalization of cannabis use for both medical and recreational users.

Last week, the Israeli Police Minister backed the easing of enforcement of existing laws, which was followed by a joint statement by the Prime Minister and Defense Minister outlining their intent to advance legislation "to resolve the issue of decriminalization and legalization" ostensibly referring to recreational cannabis use.

The statement further noted a determination to advance medical cannabis reforms in order to make it easier for patients to gain access to treatments and for growers to receive permits.

The report indicated agreement on an outline for reform that includes; cannabis to be permitted only for those over the age of 21, excludes those in security-related occupations; prohibits driving under the influence of cannabis and went on to note sales will only be permitted through authorized outlets, and there will be restrictions on cannabis advertising. Many government and public figures are echoing support for responsible national reform initiatives.

"We are incredibly pleased by the recent news and are highly supportive of the initial proposals moving towards medical and recreational reform," said Darryl Jones, Chief Executive Officer of Isracann. "We look forward to building on this legislative framework as we continue to execute our strategic plans in the region."

HelloMD, the leading virtual healthcare platform for medical cannabis in Canada, announced that it is offering a new Senior Care service that gives 65+ patient community across Canada simpler access to medical cannabis support to help keep them informed and cared for during COVID-19.

HelloMD is the exclusive telehealth partner of Medical Cannabis by Shoppers, Shoppers Drug Mart's online platform for the sale of medical cannabis. Through the partnership HelloMD provides patients in Canada with convenient access to practitioner-led advice about medical cannabis.

HelloMD's new Senior Care service offers low-tech, high-touch access to educational content and licensed practitioners, all from the safety and comfort of their homes. The service offers seniors a simple 3-step process that connects them with an experienced practitioner and, if authorized, with a Medical Cannabis by Shoppers virtual pharmacists to assist with product prescriptions and fulfillment.

According to Statscan National Cannabis Survey seniors are the fastest growing age group utilizing cannabis. With more than a quarter of 65+ cannabis users new to cannabis, the need for education and services that cater specifically to them is clear.

"It's no surprise that we see so many more seniors curious about using medical cannabis," said Wendy Wiley, RN, MN, NP. "From my experience, this is a group more likely to present with symptoms resistant to first and second line treatment options, or to be experiencing intolerable side effects from other treatments. But cannabis is not a silver bullet; seniors need access to sound advice on how to use medical cannabis safely, in the context of their conditions and other currently prescribed medications," added Wiley.

The new Senior Care service also includes regularly updated educational content tailored around the needs of those seniors using or seeking advice on the use of medical cannabis.

"Since the start of 2020, we have seen more than 250% growth in demand from 65+ patients seeking practitioner advice on medical cannabis," said Larry Lisser Senior Vice President of HelloMD. With the ongoing associated risks of COVID-19, seniors need access to safe and trusted sources for their health care needs; yet virtual health is new and sometimes can feel cumbersome for this community. That's why we have re-engineered our processes and platform so that seniors can enjoy the safety and convenience of virtual health services, but without the frustration that technology can sometimes present," Lisser added.

"We want seniors to have trusted access to the widest variety of medical cannabis products available in Canada today, " said Ken Weisbrod, Vice President of Business Development, Shoppers Drug Mart. "Be it by way of simpler access to licensed practitioners, or our pricing programs designed to help seniors better afford their medical cannabis, we want to ensure that seniors have the support they need to streamline this aspect of their healthcare journey.".

Radient Technologies Inc. (TSX-V: RTI) (OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, announced that its recently launched bioU branded products are now available through Medical Cannabis by Shoppers, a subsidiary of Shoppers Drug Mart Inc.

The bioU brand was created exclusively for Medical Cannabis by Shoppers and is now available across Canada. bioU products have been scientifically designed by Radient to provide a high quality, consistent, broad spectrum oil formulations to medical users. The first series of products to launch is the USpray line of extracts which come in a convenient, precise dosage oral spray format. A CBD dominate (1:20 ratio of THC:CBD) and balanced formulation (1:1 ratio of THC:CBD) are now available, with a THC dominate formula (30:1 ratio of THC:CBD) expected shortly.

The Company has also received the approval from the TSX Venture Exchange for a series of shares for debt agreements with various of its creditors, which was previously announced in a press release dated May 8, 2020 under the terms and conditions noted in the press release.

American Green (OTC: ERBB) announced today that the strategic shifts that began in 2019 are now paying dividends in every division. According to David Gwyther, president of American Green, "During 2019 and early 2020, the company had to make changes in every division to accommodate the changing marketplace. I'm pleased to report that those changes resulted in each division's revenue improvements compared to the same periods over the previous year."

VP of CBD Worldwide Sales, Kevin Davis, said, "The key to the success of the American Green Online CBD Store is a combination of Top-Shelf Customer Service, The Integration of Technology, Competitive Pricing, Easy Payment Options, and Product Selection. Since our online CBD Store first opened 3 years ago, our growth has been primarily driven by our extreme sensitivity to customer feedback -- by listening very, very carefully. Whether that means incorporating a capability to quickly respond to customer questions via email or phone, and making damn sure our customers know that they're getting the best CBD available and are 100% satisfied, even if that means staying on the phone with them until they get all the information they need."

"Every customer is unique to us and when our store employees show them the courtesy of our unrushed time -- whether by email or phone, it is the only way we know of guaranteeing that our loyal base returns to us. Other companies talk about achieving goals like these, but we, at the American Green CBD Store live this 'customer-driven lifestyle' every day," concludes Kevin.

According to Bryan Croteau, American Green's VP of Grow Operations, "As the world comes out of quarantine and things get back to the 'new normal,' American Green's 'Sweet Virginia' is turning out some of the highest grade cannabis found in Arizona and is hard at work upgrading its production facility while producing American Green's newest cannabis product line. Our Sweet Virginia facility is proud to announce that the first wave of American Green Full Spectrum Solventless Concentrate products have hit the retail shelves at the Kind Meds licensed dispensary located at 2152 South Vineyard, Suite 120, Bldg 7, Mesa AZ 85210."

American Green's Sweet Virginia grow operation is most proud of its Ice-water-extracted Bubble Hash which is also known as "Full Melt," because it leaves no residue when compared to standard hash which has been made the same way for hundreds of years. According to Mr. Croteau, "Our special process manually removes the THC trichomes using nothing but ice and water and produces one of the safest and most natural concentrates available anywhere. If you are a current medical patient in the State of Arizona, we highly recommend a trip to Kind Meds for an opportunity to taste our best grown flowers in the form of concentrate! I would call first before making the trip to ensure that the American Green Bubble Hash has not been sold out, as we anticipate high demand for this premium product."

The Sweet Virginia Grow has also recently added 10% of canopy space as an additional flower room thus enabling the operation to increase its revenues by about 10% per annum. This new space will allow for production of an extra 240 plants every 8 weeks. We are also constantly streamlining tasks to be as efficient as possible, which has allowed us to cut our current payroll costs by about 12% when compared to last quarter.

The American Green Machine (AGM) Division has been working to add new features to its Smart Vending Kiosk such as lower risk touchless shopping which will allow vending customers to utilize a QR Code and be able to use their own cell phone to interact with our AGM Kiosk. Employing "Covid-19 Sensitivity," customers will no longer need to touch the machine to view the AGM's products with the goal of allowing customers to complete their entire transaction on their smartphone. This new feature has been designed to be "backwards compatible" thus enabling the feature to be available for existing machines already in service and is now ready to rollout. According to AGM Division VP, Lindel Creed,

"We are very excited with the progress of the AGM kiosk as sales increase this year and more customers become convinced that the AGM is the best verified vending system on the market."

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

Hear Investor ideas cannabis potcast on iTunes

Hear the investor ideas potcast on Spotify

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Follow us on Cannabis Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/investorideas_potcast/

Download our Mobile App for iPhone and Android

Contact Investorideas.com

800-665-0411


Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories

Buy a cannabis guest post on Investorideas.com